BIOMAT Database Logo BIOMAT Database Logo

Prognostic significance of type IV collagen and laminin immunoreactivity in urothelial carcinomas of the bladder. 1990

R F Schapers, and R P Pauwels, and M G Havenith, and A W Smeets, and P A van den Brandt, and F T Bosman
Department of Pathology, Stichting Ziekenhuizen Venlo-Venray, The Netherlands.

Invasion of a carcinoma involves the degradation and penetration of the subepithelial basement membrane (BM). This phenomenon might be used for histopathologic evaluation of neoplasms of the bladder. The authors studied the clinicopathologic data and tissue specimens of 125 cases of urothelial carcinomas collected prospectively. Penetration of the BM was evaluated by immunohistochemical staining of the BM components laminin and type IV collagen. The use of this parameter as a prognostic indicator in bladder cancer was assessed. The 5-year survival rate of patients having tumors with an interrupted or absent BM was significantly lower than that of patients having tumors with an intact BM. The rate of progression was greater in tumors with an interrupted or absent BM than in tumors with an intact BM. No association was found between BM status and recurrence. However, a significant correlation between tumor stage and BM staining was found. A correlation was also found between ploidy and BM staining as well as between histologic grade and BM staining pattern. When evaluating histologic grade, stage, ploidy, age, and BM score as prognostic parameters, the stage of bladder carcinomas turned out to be the most important factor in predicting the survival rate and the progression-free survival. However, BM staining was found to be of value for early identification of microinvasion and is helpful for correct staging of urothelial carcinomas.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D007797 Laminin Large, noncollagenous glycoprotein with antigenic properties. It is localized in the basement membrane lamina lucida and functions to bind epithelial cells to the basement membrane. Evidence suggests that the protein plays a role in tumor invasion. Merosin,Glycoprotein GP-2,Laminin M,Laminin M Chain,Chain, Laminin M,Glycoprotein GP 2,M Chain, Laminin
D011003 Ploidies The degree of replication of the chromosome set in the karyotype. Ploidy
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D001749 Urinary Bladder Neoplasms Tumors or cancer of the URINARY BLADDER. Bladder Cancer,Bladder Neoplasms,Cancer of Bladder,Bladder Tumors,Cancer of the Bladder,Malignant Tumor of Urinary Bladder,Neoplasms, Bladder,Urinary Bladder Cancer,Bladder Cancers,Bladder Neoplasm,Bladder Tumor,Cancer, Bladder,Cancer, Urinary Bladder,Neoplasm, Bladder,Neoplasm, Urinary Bladder,Tumor, Bladder,Tumors, Bladder,Urinary Bladder Neoplasm
D002295 Carcinoma, Transitional Cell A malignant neoplasm derived from TRANSITIONAL EPITHELIAL CELLS, occurring chiefly in the URINARY BLADDER; URETERS; or RENAL PELVIS. Carcinomas, Transitional Cell,Cell Carcinoma, Transitional,Cell Carcinomas, Transitional,Transitional Cell Carcinoma,Transitional Cell Carcinomas
D003094 Collagen A polypeptide substance comprising about one third of the total protein in mammalian organisms. It is the main constituent of SKIN; CONNECTIVE TISSUE; and the organic substance of bones (BONE AND BONES) and teeth (TOOTH). Avicon,Avitene,Collagen Felt,Collagen Fleece,Collagenfleece,Collastat,Dermodress,Microfibril Collagen Hemostat,Pangen,Zyderm,alpha-Collagen,Collagen Hemostat, Microfibril,alpha Collagen
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001485 Basement Membrane A darkly stained mat-like EXTRACELLULAR MATRIX (ECM) that separates cell layers, such as EPITHELIUM from ENDOTHELIUM or a layer of CONNECTIVE TISSUE. The ECM layer that supports an overlying EPITHELIUM or ENDOTHELIUM is called basal lamina. Basement membrane (BM) can be formed by the fusion of either two adjacent basal laminae or a basal lamina with an adjacent reticular lamina of connective tissue. BM, composed mainly of TYPE IV COLLAGEN; glycoprotein LAMININ; and PROTEOGLYCAN, provides barriers as well as channels between interacting cell layers. Basal Lamina,Basement Lamina,Lamina Densa,Lamina Lucida,Lamina Reticularis,Basement Membranes,Densas, Lamina,Lamina, Basal,Lamina, Basement,Lucida, Lamina,Membrane, Basement,Membranes, Basement,Reticularis, Lamina
D015996 Survival Rate The proportion of survivors in a group, e.g., of patients, studied and followed over a period, or the proportion of persons in a specified group alive at the beginning of a time interval who survive to the end of the interval. It is often studied using life table methods. Cumulative Survival Rate,Mean Survival Time,Cumulative Survival Rates,Mean Survival Times,Rate, Cumulative Survival,Rate, Survival,Rates, Cumulative Survival,Rates, Survival,Survival Rate, Cumulative,Survival Rates,Survival Rates, Cumulative,Survival Time, Mean,Survival Times, Mean,Time, Mean Survival,Times, Mean Survival

Related Publications

R F Schapers, and R P Pauwels, and M G Havenith, and A W Smeets, and P A van den Brandt, and F T Bosman
Laminin and type IV collagen in experimental rat oral carcinomas.
May 1993, Journal of comparative pathology,
R F Schapers, and R P Pauwels, and M G Havenith, and A W Smeets, and P A van den Brandt, and F T Bosman
The prognostic significance of nuclear CSE1L in urinary bladder urothelial carcinomas.
October 2012, Annals of diagnostic pathology,
R F Schapers, and R P Pauwels, and M G Havenith, and A W Smeets, and P A van den Brandt, and F T Bosman
Prognostic significance of angiogenesis and immunoreactivity of cathepsin D and type IV collagen in high-grade stage T1 primary bladder cancer.
July 1999, Urology,
R F Schapers, and R P Pauwels, and M G Havenith, and A W Smeets, and P A van den Brandt, and F T Bosman
Immunoreactivity for laminin and type IV collagen in malignant and benign fibrous histiocytoma.
July 1989, The Journal of pathology,
R F Schapers, and R P Pauwels, and M G Havenith, and A W Smeets, and P A van den Brandt, and F T Bosman
[Laminin and collagen (type IV)].
August 2002, Nihon rinsho. Japanese journal of clinical medicine,
R F Schapers, and R P Pauwels, and M G Havenith, and A W Smeets, and P A van den Brandt, and F T Bosman
Prognostic significance of tumor budding in muscle invasive urothelial carcinomas of the bladder.
July 2019, Turkish journal of urology,
R F Schapers, and R P Pauwels, and M G Havenith, and A W Smeets, and P A van den Brandt, and F T Bosman
Prognostic significance of tumor budding in muscle invasive urothelial carcinomas of the urinary bladder.
October 2021, Annals of diagnostic pathology,
R F Schapers, and R P Pauwels, and M G Havenith, and A W Smeets, and P A van den Brandt, and F T Bosman
Alterations in the immunoreactivity of laminin, type IV collagen and α3β1 integrin in diabetic rat ovarian follicles.
January 2020, Bratislavske lekarske listy,
R F Schapers, and R P Pauwels, and M G Havenith, and A W Smeets, and P A van den Brandt, and F T Bosman
Laminin and type IV collagen in the human testis.
October 1985, International journal of andrology,
R F Schapers, and R P Pauwels, and M G Havenith, and A W Smeets, and P A van den Brandt, and F T Bosman
Clinical significance of serum laminin and type-IV collagen levels in cutaneous melanoma patients.
July 2016, Molecular and clinical oncology,
Copied contents to your clipboard!